Related references
Note: Only part of the references are listed.Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline
Jorge L. Del-Aguila et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden
Tenielle Porter et al.
SCIENTIFIC REPORTS (2018)
Genetic Variants Associated With Risk of Alzheimer's Disease Contribute to Cognitive Change in Midlife: The Atherosclerosis Risk in Communities Study
Jan Bressler et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2017)
Genetic Risk as a Marker of Amyloid-beta and Tau Burden in Cerebrospinal Fluid
Nicola Voyle et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease
Burcu F. Darst et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
A. Lacour et al.
MOLECULAR PSYCHIATRY (2017)
Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score
Rahul S. Desikan et al.
PLOS MEDICINE (2017)
Polygenic Risk Score Analysis of Pathologically Confirmed Alzheimer Disease
Escott-Price Valentina et al.
ANNALS OF NEUROLOGY (2017)
Multimodal Brain Imaging Reveals Structural Differences in Alzheimer's Disease Polygenic Risk Carriers: A Study in Healthy Young Adults
Sonya F. Foley et al.
BIOLOGICAL PSYCHIATRY (2017)
Defining the Genetic Architecture of Alzheimer's Disease: Where Next?
Rebecca Sims et al.
NEURODEGENERATIVE DISEASES (2016)
Using an Alzheimer Disease Polygenic Risk Score to Predict Memory Decline in Black and White Americans Over 14 Years of Follow-up
Jessica R. Marden et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2016)
Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment
Eva Louwersheimer et al.
ALZHEIMERS & DEMENTIA (2016)
Potential contribution of the Alzheimer's disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly
Lior Greenbaum et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease
Vincent Chouraki et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study
Samantha C. Burnham et al.
LANCET NEUROLOGY (2016)
Association of genetic risk factors with cognitive decline: the PATH through life project
Shea J. Andrews et al.
NEUROBIOLOGY OF AGING (2016)
The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume
Michelle K. Lupton et al.
NEUROBIOLOGY OF AGING (2016)
Polygenic risk of Alzheimer disease is associated with early- and late-life processes
Elizabeth C. Mormino et al.
NEUROLOGY (2016)
Advanced brain aging: relationship with epidemiologic and genetic risk factors, and overlap with Alzheimer disease atrophy patterns
M. Habes et al.
TRANSLATIONAL PSYCHIATRY (2016)
An Alzheimer's Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults
Theresa M. Harrison et al.
ENEURO (2016)
Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia
Hieab H. H. Adams et al.
ALZHEIMERS & DEMENTIA (2015)
A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42
Kristel Sleegers et al.
ALZHEIMERS & DEMENTIA (2015)
Common polygenic variation enhances risk prediction for Alzheimer's disease
Valentina Escott-Price et al.
BRAIN (2015)
Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease
Minerva M. Carrasquillo et al.
NEUROBIOLOGY OF AGING (2015)
Association of Alzheimer's disease GWAS loci with MRI markers of brain aging
Ganesh Chauhan et al.
NEUROBIOLOGY OF AGING (2015)
Comparison of MR-less PiB SUVR quantification methods
Pierrick Bourgeat et al.
NEUROBIOLOGY OF AGING (2015)
Effects of Alzheimer's Disease-Associated Risk Loci on Cerebrospinal Fluid Biomarkers and Disease Progression: A Polygenic Risk Score Approach
Henna Martiskainen et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease
Y. Y. Lim et al.
MOLECULAR PSYCHIATRY (2015)
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-beta Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
Qiao-Xin Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study
Samantha C. Burnham et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects
Otto Pedraza et al.
ALZHEIMERS & DEMENTIA (2014)
COMPARISON OF THREE NORMATIVE DATA CORRECTION APPROACHES: A CROSS-SECTIONAL EVALUATION IN THE AIBL STUDY
Samantha Burnham et al.
Alzheimers & Dementia (2014)
CR1, ABCA7, and APOE genes affect the features of cognitive impairment in Alzheimer's disease
Sun Ju Chung et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Influence of Alzheimer's disease genes on cognitive decline: the Guangzhou Biobank Cohort Study
Hongsheng Gui et al.
NEUROBIOLOGY OF AGING (2014)
The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials
Reisa Sperling et al.
NEURON (2014)
Alzheimer's Disease Genetics: From the Bench to the Clinic
Celeste M. Karch et al.
NEURON (2014)
Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer's Disease
Ying Liu et al.
PLOS ONE (2014)
The Preclinical Alzheimer Cognitive Composite Measuring Amyloid-Related Decline
Michael C. Donohue et al.
JAMA NEUROLOGY (2014)
Predicting Alzheimer Disease with β-Amyloid Imaging: Results from the Australian Imaging, Biomarkers, and Lifestyle Study of Ageing
Christopher C. Rowe et al.
ANNALS OF NEUROLOGY (2013)
Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease
E. Rodriguez-Rodriguez et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease
Yen Ying Lim et al.
NEUROBIOLOGY OF AGING (2013)
Screening for predementia AD Time-dependent operating characteristics of episodic memory tests
Carol A. Derby et al.
NEUROLOGY (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Alzheimer's Disease: Analyzing the Missing Heritability
Perry G. Ridge et al.
PLOS ONE (2013)
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Hugo Vanderstichele et al.
ALZHEIMERS & DEMENTIA (2012)
The Association between a Polygenic Alzheimer Score and Cortical Thickness in Clinically Normal Subjects
Mert R. Sabuncu et al.
CEREBRAL CORTEX (2012)
Longitudinal Assessment of A beta and Cognition in Aging and Alzheimer Disease
Victor L. Villemagne et al.
ANNALS OF NEUROLOGY (2011)
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Christopher M. Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj et al.
NATURE GENETICS (2011)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth et al.
NATURE GENETICS (2011)
18F-Flutemetamol Amyloid Imaging in Alzheimer Disease and Mild Cognitive Impairment A Phase 2 Trial
Rik Vandenberghe et al.
ANNALS OF NEUROLOGY (2010)
Genetic Variation and Neuroimaging Measures in Alzheimer Disease
Alessandro Biffi et al.
ARCHIVES OF NEUROLOGY (2010)
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Christopher C. Rowe et al.
NEUROBIOLOGY OF AGING (2010)
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
Kathryn A. Ellis et al.
INTERNATIONAL PSYCHOGERIATRICS (2009)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold et al.
NATURE GENETICS (2009)
Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE
Lars Bertram et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Role of genes and environments for explaining Alzheimer disease
M Gatz et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Mild cognitive impairment -: beyond controversies, towards a consensus:: report of the International Working Group on Mild Cognitive Impairment
B Winblad et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Share Paper
